|
Market Closed -
NYSE
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 1.080 USD | -1.82% |
|
-1.82% | -35.33% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-06 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 273M 235M 221M 202M 377M 25.83B 378M 2.62B 1.01B 13.23B 1.03B 1B 42.14B | P/E 2026 * |
-16.1x | P/E 2027 * | -10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 273M 235M 221M 202M 377M 25.83B 378M 2.62B 1.01B 13.23B 1.03B 1B 42.14B | EV / Sales 2026 * |
18x | EV / Sales 2027 * | 16.2x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| LCTX | Delayed | |
CBOE
| LCTX | Real-time | |
|
TEL AVIV STOCK EXCHANGE
| LCTX | Delayed | |
|
Tradegate
| BT3 | Real-time | |
|
Deutsche Boerse AG
| BT3 | Delayed | |
|
Börse Stuttgart
| BT3 | Delayed | |
|
Boerse Muenchen
| BT3 | Real-time |
Last Transcript : Lineage Cell Therapeutics, Inc.
| 1 day | -1.82% | ||
| 1 week | -1.82% | ||
| Current month | -1.82% | ||
| 1 month | -1.82% | ||
| 3 months | -9.24% | ||
| 6 months | -41.62% | ||
| Current year | -35.33% |
| 1 week | 1.08 |  | 1.14 |
| 1 month | 1.04 | | 1.18 |
| Current year | 1 | | 1.98 |
| 1 year | 1 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.71 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 2018-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 2022-11-13 |
Priyantha Herath
CTO | Chief Tech/Sci/R&D Officer | - | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 2009-06-30 |
Deborah Andrews
BRD | Director/Board Member | 68 | 2014-04-10 |
Michael Mulroy
CHM | Chairman | 60 | 2024-04-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/1/26 | Free | Director | 125,000 | 0.0501% | ||
| 7/1/26 | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 7/1/26 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.82% | -1.82% | -11.48% | -21.74% | 273M | |
| -1.16% | -2.77% | -2.91% | +13.85% | 48.93B | |
| -0.40% | +2.16% | +418.57% | +554.47% | 45.01B | |
| -1.42% | +2.52% | +42.67% | +22.27% | 44.07B | |
| -1.22% | -0.37% | +4.82% | +84.42% | 40.73B | |
| -0.96% | -1.38% | +15.75% | +45.91% | 33.52B | |
| -0.21% | +2.86% | - | - | 17.77B | |
| -0.35% | -0.45% | +21.42% | +117.63% | 16.5B | |
| -1.54% | -1.30% | +12.16% | +31.14% | 14.67B | |
| -1.65% | +0.09% | +75.93% | +41.15% | 13.77B | |
| Average | -1.07% | -0.02% | +64.10% | +98.79% | 27.53B | |
| Weighted average by Cap. | -1.00% | -0.05% | +88.85% | +134.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.19M 13.07M 12.29M 11.22M 20.98M 1.44B 21.05M 146M 56.32M 736M 57.06M 55.81M 2.34B | 16.83M 14.48M 13.62M 12.43M 23.25M 1.59B 23.32M 161M 62.41M 815M 63.22M 61.84M 2.6B |
| Net income | -22.64M -19.47M -18.31M -16.72M -31.26M -2.14B -31.37M -217M -83.93M -1.1B -85.02M -83.16M -3.49B | -34.44M -29.62M -27.86M -25.43M -47.56M -3.26B -47.71M -330M -128M -1.67B -129M -127M -5.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$1.080 | -1.82% | 535,726 |
| 26-09-03 | US$1.100 | -0.90% | 917,013 |
| 26-09-02 | US$1.110 | +2.78% | 675,975 |
| 26-09-01 | US$1.080 | -1.82% | 905,661 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
